-
-
-
-
-
-
-
Eli Lilly & Co. (LLY) to Acquire Morphic (MORF) for $57/sh Cash or $3.2B
-
-
-
-
-
-
-
Morphic Announces that AbbVie Exercises License Option to αvβ6 Integrin Inhibitor Program, Including MORF-720, for Fibrotic Diseases
-
-
-
-
-
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

